Predictive analytics could unlock precision medicine progress: AiCure
An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.
An expert from the clinical insight specialist shares how predictive analytics could reveal info about medication adherence, disease progression, and more.
Mark Doyle, co-founder of The Method and creator of the A Life in a Day programme, tells us about the immersive experience he and his […]
An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.
According to the World Health Organization (WHO), approximately 296 million people globally live with hepatitis B, with most unaware of their infection. Africa is the […]
A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.
Seqster has attracted another pharma partner for its patient data technology, which aims to improve care through better access and understanding of patient-level real-world data […]
During the World Orphan Drug Congress, a co-founder of the CRO outlined how patient perspective can be vital to better results in rare-disease research.
The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Bidenâs call to improve screening and treatment options.
A leader from the CRO discusses how capturing the perspective of trial participants can help ensure development of treatments that meet the patientsâ needs.
The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.
The CRO and medical genetics company will collaborate to accelerate trials centered on rare diseases, using real-world data and genetic testing technology.
The Foundation for Sarcoidosis Research hosted more than 50 agency leaders in a session that addressed patient concerns in research, care, and diagnosis.
Face-to-face discussion educates regulators on what matters most to patients, and guides future decision-making. Regulators are increasingly asking drug developers to include the patient voice […]
Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.
A study out of Israel’s Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.
The immediate threat to patient care from COVID-19 has diminished with the passing of the acute phase of the pandemic, but its impact continues to […]
SAE Media Group’s Inaugural Conference… Medical Devices and IVD 2022 14 – 15 November 2022 London, UK http://www.medicaldevices-ivd.com Navigating The MDR and IVDR and Best […]
The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.
The company has added Type 2 diabetes to the list of conditions it simulates in itâs A Life in a Day program, enabling people to […]
The sponsorship from Janssen Pharmaceutical Companies will be used by the cancer support network to boost diversity in Phase I and Phase 2 clinical trials.
Six in 10 respondents to Health Union’s Spondyloarthritis In America 2021 survey said they feel other people in their lives don’t understand the risks of being immunocompromised. […]
Parexel’s Community Alliance Network, designed to more deeply integrate clinical research into community healthcare, has invited Javara and CVS as members
A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to […]
Representatives from Clincierge, Rare Patient Voice, Insight and Measurement, and Ultragenyx Pharmaceutical will lead the lively panel discussion on June 13.
American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation […]
A Touch, the Black Breast Cancer Alliance leader discusses how a grant from Genentech is helping the organization break down barriers in care and research.
To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in oncology prevention, diagnosis, therapy and care over […]
Through its Health Equity and Diversity in STEM Innovation Fund, the biotech is looking to increase equity in care and diversify the scientific workforce.
An expert from health data and analytics solutions provider H1 explains how technology can help address the disparities in clinical trial and care access.
The DATAcc has released a collection of open-access resources that are intended to help users build inclusivity into digital health measurement products.
As healthcare evolves to become more consumer-centric, the value of social health – the dynamic, real-time action people take to find meaningful connections and share […]
An expert from the AI-focused technology company shares insights as to how it can be harnessed to better interpret, and even predict, patient behavior.
The institute will combine the universityâs AI, ML, health science, engineering, genomics, and data capabilities to tackle health strategy and inequity.
IllumiCare has added the app to its Smart Ribbon point-of-care information tool, enabling providers to connect patients to appropriate clinical studies.
Leaders from the biotech company share advice on how such organizations can make the most of often limited resources via smart strategy and collaboration.
People who trust pharma are more interested in using the industry’s services – making building confidence in the sector key to realising the potential of […]
The clinical trial tech firm has announced a $220m Series D funding round which will boost its efforts to improve inclusivity and representation in studies.
The pharmaceutical firm and university have launched T-REX, a multi-year partnership focused on increasing health outcomes for underrepresented populations.
A leader from the life-science organization discusses how collaboration could lead to a broad range of benefits for everyone along the drug discovery pipeline
With patient-centricity, holistic health and treating the whole person as omnipresent topics of industry conversation, it’s evident that pharma plays a role in providing value […]
Social health: the dynamic, real-time actions people take to find meaningful connections and share information along their health journey.Through social health, pharma marketers can reach patients […]
The recruitment tech specialist has added oncology clinical studies to its marketplace, providing sponsors with a larger pool of patients to choose from.
The Pancreatic Cancer Action Network has engaged five new clinical trial sites in the US, which will aid in evaluation of Novartisâ investigational therapy.
The pharmaceutical company’s clinical study is intended to examine critical gaps in care for people of color living with moderate to severe plaque psoriasis.
A leader from the patient recruitment specialist discusses the industryâs ongoing challenges with patient population diversity, and potential solutions.
A leader from the trial platform company discusses how patient experience can be enhanced when the clinical trial team shares a background with the subjects.
The Seeker Health digital patient enrollment platform is intended to help trial teams find patients from populations that are typically hard to connect with.
Cloud-based Clarify Trials is real-world evidence-based software intended to improve recruitment of clinical study patients from underrepresented communities.
The pharmaceutical company has announced 24 grants totaling nearly $8m USD to fuel training and support for community health workers and patient navigators.
With two decades of experience as a practicing psychiatrist, mdgroup medical director Arthur Lazarus offers broad experience and strong patient advocacy.
Patient-centric company Belong.life has developed an app designed to inform cancer research by offering a holistic view of the lives of people with cancer.
A leader from the Syneos Health company explains how innovative tech can elevate patient recruitment and engagement, even with the challenges DCTs can face.
Ergomed, a global contract research organization, is partnering with Trialbee to improve patient recruitment at its new Rare Disease Innovation Center.
The AI-centered genomics company is joining with Donât Forget Morgan, a group for patients with BPAN, to explore treatments for the neurodegenerative condition.
In its latest diversity, equity and inclusion report, Global Genes offers insight into obstacles faced by rare-disease patients from minority communities.
Nothing quite compares to the level of solace patients find in connecting with others who share similar health experiences. These interactions have become so fundamental […]
On February 23, five days ahead of the day of rare-disease awareness, OSPâs Rare and Orphan Diseases webinar will share insights from top industry experts.
The companyâs analysis of trials conducted around the world last year shows cancers took four of the top five positions, with COVID-19 in second place.
The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.
The precision medicine company is joining with decentralized trial specialist Curebase to bring its cancer studies to a more diverse group of patients.
The rise in the use of decentralised clinical trial (DCTs) designs forced by COVID-19 looks set to outlast the pandemic, and digital health company Seqster […]
During OSPâs exclusive February 23 webinar Rare and Orphan Diseases, leading expertswill lend their unique experience and expertise to the important topic.
On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.
Real-World Evidence 2022: Rare Diseases and Innovative Therapies (RWE 2022) will convene the full spectrum of stakeholders working in RWE in rare diseases and innovative […]
One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.
An expert from patient solutions firm Trialbee discusses how the social media firm’s recent ban on targeted advertising might impact patient recruitment.
We spoke with Tanja Dowe, ahead of the annual J.P. Morgan Health Care Conference 2022, about radical innovation in healthcare, including the potential of digital […]
For the past ten years we’ve seen a steady acceptance of the need for patient engagement practises to become routine and integrated into all systems […]
Patient centricity and patient engagement have been hot topics in pharma for some time – but buzz words do not always translate into concrete action. […]
The organization is working to give oncology professionals the chance to hear directly from patients about their unique experiences, concerns, and hopes.
Words matter. In the pharma industry, “patient engagement” and “patient centricity” might seem like interchangeable bits of corporate jargon. But the difference between them is […]
According to a leader from the virtual engagement solutions company, gaps in trial communications can be improved with the intelligent use of technology.
The organizations have issued an in-depth look on issues impacting inclusivity, why change is needed, and potential solutions for increasing trial diversity.
Health Union surveyed 2,371 patients across a diverse representation of health conditions to better understand how social health can positively impact patient experiences. The survey found […]
An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.
Leaders from IQVIA and its Q2 Solutions division offer advice on how to deal with mobile teams, home health providers, and other aspects of virtual […]
Patient data from the clinical solutions company indicates that gains in recruitment of Black participants is outpacing that of patients from other groups.
The StudyTeam Diversity Reporting feature is intended to aid sites and sponsors measure their efforts to reach patients from underrepresented communities.
During our November 17 webinar Patient-centric solutions, a group of professionals representing a range of perspectives will share ideas and innovations.
After 30 yearsâ experience, including stints advising top pharma firms, the expert has joined a firm offering tech aimed at elevating patient ID and enrollment.
During OSPâs November 17 online event, a group of experts will offer insights, advice, and examples of solutions that put patients at the center of […]
A leader from the language and tech solutions firm explains how multilingual support can improve patient recruitment and other aspects of clinical trials.
The radvocacy group is joining with the Rare Disease Diversity Coalition on an initiative to identify and overcome challenges faced by minority patients.
With the launch of its Trialbee Honey technology, the company aims to bring together recruitment information from different sources for sweeter results.
RSG Arrive is intended to increase clinical trial participation by offering ground transport, plane rides, hotels, visa procurement, and other services.
Panelists at HLTH’s patient engagement track, hosted by MedCity News, zeroed in on three strategies for achieving patient centricity: building trust, engaging health navigators and […]
SMi Group Proudly Presents… Medical Wearables for Biosensors USA Conference 2021 Conference: 25 – 26 October 2021 Virtual Conference: Online Access Only Website: www.biosensors-medical-wear.com/pharmaphorum Exploring […]
Health journeys can be complex, sometimes more complex than a Rube Goldberg machine or spelling, say, embourgeoisement or consanguineous. And certain aspects of living with […]
A leader from the division of Eli Lilly explains the importance of driving greater trial inclusivity, and why collaboration is vital in making progress.
Digital data collection, utilisation of real-word data and patient-centric thinking will all contribute to the rapid development of a new healthcare landscape, says Debiopharm Innovation […]
The COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and commercialisation. In some cases it was an […]
A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.
The pharmaceutical firm has tapped the decentralized research organization in order to help elevate the inclusivity of its oncology trials at all levels.
Access to online social connections has transformed the patient journey, and your brand strategy can evolve with it to effectively meet patients where they are. […]
Two experts from the contract research organization offer advice on planning and executing clinical studies with the unique needs of such patients in mind.
Not enough is being done to ensure that patient voices are included in policymaking around digital health, says a new patient organisation in the UK, […]
The advocacy organization’s PIE4CNS initiative is aimed at targeting and reducing gaps in diagnosis, research, and trials for rare neurological conditions.
Two leaders from the decentralized trial solutions provider discuss the complex pieces of a global clinical study and how to work to fit them all […]
A representative from Cmed explains how taking stock of existing tech and adding the right new tools can help when switching to virtual clinical studies.
A leader from Illingworth Research Group outlines exactly what makes a good mobile research nurse and what their duties in decentralized trials are.
A leader from the home trial services provder says patientsâ increasing awareness of clinical research has how trial teams should consider their approach.
This year’s World Hepatitis Day theme, ‘Hepatitis Can’t Wait,’ stresses the urgency of testing and treating viral hepatitis, as well as removing the stigma surrounding […]
The #BlackDataMatters movement aims to improve outcomes for Black women living with breast cancer by increasing their presence in vital clinical research.
Cota has released a survey revealing about two-thirds of cancer patients and their families are unsatisfied at the speed of cancer treatment development.
Before developing any stakeholder engagement plan, it is crucial to have a clear understanding of all the relevant individuals and groups your product or device […]
The regional US healthcare system will collaborate with the health intelligence specialist to advance precision medicine focused on oncological care.
The CRO has launched an initiative that offers help navigating regulatory issues for ultra-rare disease patient advocacy groups that demonstrate a need.
The patient matching platform firm will work with Precision for Medicine on solutions to increase diversity, elevate enrollment and speed new therapies.
The check-in with nearly 1,800 US healthcare consumers reflects how COVID-19 and other factors have impacted patient access, equity, experience and trust.
The clinical study network is partnering with the Wisconsin-based health system to increase the reach of trials into a largely rural patient population.
With advertisers preparing to spend up to $15 billion on influencer marketing by 2022, pharmaceutical and biotech companies are increasingly (and carefully) engaging trusted health social […]
A leader from Longboat by Advarra outlines what it really means for a study to be patient centric, and how to succeed in achieving patient-centric […]
The pharma firm’s partnership with 26 US Black colleges includes a $13.7m investment in trial and research centers at Morehouse School of Medicine.
The two organizations have joined to create the Advocacy Exchange, a virtual platform designed to bring together patients, advocates and industry leader.
On July 7, a group of seasoned industry leaders will offer insights at Rare/orphan diseases, special patient population, a focused, free online event.
The trial solutions firm is working with Childrenâs Oncology Group to expand in-home research and care options for investigational immune-oncology therapy.
The research collaboration is aimed at studying disparities in care with a focus on multiple myeloma, a cancer disproportionately affecting Black patients.
United BioSource received the 2021 Healthiverse Heroes Award for Life Sciences in recognition of its automated clinical trial patient outreach technology.
Health Union, the leader in building online health solutions for people living with chronic conditions, today announced that it has acquired WEGO Health, the world’s […]
The pharma firm is collaborating with oncology organizations on Nothing Small About it, a resource for small-cell lung cancer patients and their loved ones.
COUCH Health, a patient engagement agency, announced the appointment of Mark Duman as its Chief Strategy Officer (CSO). Taking charge of strategy development and execution […]
A representative from Thermo Fisher Scientific addresses how bringing research and resources directly to participants can address problems with studies.
The decentralized trial tech provider and patient-matching specialist will collaborate in the hopes of improving inclusivity and recruitment outcomes.
MANCHESTER, United Kingdom, May 20, 2021— COUCH Health, a patient engagement agency, has released new research exploring reasons behind the underrepresentation of ethnic minorities in US […]
A report by analyst outfit Everest Group revealed in a survey, industry professionals awarded the companyâs pharma safety services favorable reviews.
Real-world data is a vital part of rare disease drug development, but to get a true picture of patients’ unmet needs pharma should take a […]
It’s fair to say this is the most interesting time ever for market access. Not only has COVID forced companies, governments and healthcare systems to […]
A leader from the CRO talks about increased use of electronic patient-reported outcomes in research, challenges of adoption, and how ePRO benefits trials.
Change is coming in the digital marketing world whether you’re ready or not. New challenges are presented for marketers as privacy measures tighten and we say […]
Digital health player Seqster has raised $12 million in first-round financing that will be used to develop its data platform, which aims to put all […]
A leader from the global CRO discusses how putting the patient first in clinical research is essential to discovering new therapies for orphan diseases.
The companyâs Patient Advisory Council brings together a range of people and perspectives to help ensure increased diversity, inclusivity and engagement.
The UK drugs regulator is now asking that all applications for new medicines or indications detail the efforts made to involve patients in the drug […]
Health Union offers patients dealing with a range of conditions ways to connect with valuable information, research opportunities and each other online.
Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves1. Advances in next-generation […]
Approximately 85% of rare diseases are genetic, offering significant opportunities to develop better treatments as our understanding of the human genome improves1. Advances in next-generation […]
March 2021 comes with mixed emotions, as people across the United States reflect on one year of life in the era of COVID-19. From a […]
March 2021 comes with mixed emotions, as people across the United States reflect on one year of life in the era of COVID-19. From a […]
A leader from the trial solutions provider discusses how the COVID-19 pandemic has accelerated the already growing interest in remote patient monitoring.
COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. […]
A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients.
A leader from the genetics diagnostic solutions company explains how putting the patient first can make the difference in orphan drug development.
An executive from the rare disease technology solutions company discusses how forcing connections with patients can boost research into such conditions.
The collaboration will leverage patientsâ biological and medical data to streamline patient identification and recruitment efforts in clinical research.
What aspects of a patient’s treatment matter most? For many, healthcare providers (HCPs) make a significant impact on how a person feels about their overall […]
Advocacy groups play a crucial role in both driving access to innovative treatment and services and educating patients and caregivers on novel breakthroughs. On average, […]
Roche’s Italian subsidiary has joined forces with digital health startup PatchAi to roll out an app that aims to support people diagnosed with cancer. Roche […]
Personalization in marketing–the practice of understanding and delivering content when and where people are ready to accept it–in any industry is key, but perhaps even […]
William Gholston, with the Tampa Bay Buccaneers football team, is donating to the Moffitt Cancer Center to fund research into cancer treatment disparities.
The firms will work to develop solutions centered on increasing diversity and inclusivity in clinical research, and addressing healthcare disparities.
The panel is intended to address ethical matters that arise around evolving data and digital conduct for all of its various business sectors.
In medical research, trust has traditionally been hard-fought for. Terms like “lab rats” and “guinea pigs” are often used in conversations about clinical trials. For […]
Welcome to Delta – the new Fishawack Health magazine. We’ve chosen to focus our first edition of the magazine on a topic close to our […]
New research from Accenture has revealed that adoption of patient support services hasn’t improved since 2015 despite increasing pharma investment. The company’s Jennifer Spada tells […]
The trials and tribulations of 2020 have brought the vital role of research, pharma, and biotech into sharp focus. But how has the push to […]
By listening to the people who are navigating this new landscape everyday.Integrating personal experiences and patient-reported data, Health Union recently hosted a one-day virtual event […]
A leader from the global CRO shares an update on their new Accellacare clinical research network, and perspective on the importance of patient centricity.
The COVID-19 pandemic has presented many obstacles, yet the healthcare industry continues to march forward to meet the needs of patients. With physical distancing, new […]
When a person is newly diagnosed with an autoimmune condition, such as psoriasis or rheumatoid arthritis, it’s not uncommon for us to hear from them […]
Takeda has partnered with patient data firm Seqster in a drive to improve care through better access and understanding of patient-level data. The partnership follows […]
The latest iteration of BBK Worldwide’s Study Voices survey reveals thoughts on decentralized studies, telehealth and other trial technology.
The rare-disease organization will work with Rady Childrenâs Institute for Genomic Medicine to help patients and their families connect with solutions
The pharmaceutical firmâs More to uS is a UK-centered campaign that shares stories of people living (and thriving) after a multiple sclerosis diagnosis.
By enabling a more hybrid approach to clinical trials with the added flexibility of telehealth, studies can improve patient-centricity, which will ultimately improve recruitment, engagement, […]
Patient experiences are evolving. How can pharma keep up?By listening to the people who are navigating this new landscape everyday. Integrating personal experiences and patient-reported […]
Achieving Standardization & Operational Excellence in Vein-to-Vein Supply As an increasing number of candidates enter the clinic and promise to be a mainstay in the […]
A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.
When aiming to reach the people who will benefit most from a given medication or therapy, patients who play an active role in treatment decisions […]
Copyright © 2024 | WordPress Theme by MH Themes